Jean-Claude Dujardin undertakes interdisciplinary study in the fields of Leishmaniasis and Sodium stibogluconate through his research. He combines Sodium stibogluconate and Leishmaniasis in his research. Jean-Claude Dujardin conducted interdisciplinary study in his works that combined Immunology and Virology. In his research, Jean-Claude Dujardin performs multidisciplinary study on Virology and Genetics. In his research, he performs multidisciplinary study on Genetics and Evolutionary biology. He undertakes multidisciplinary investigations into Evolutionary biology and Gene in his work. Gene and Biochemistry are two areas of study in which he engages in interdisciplinary research. In his articles, he combines various disciplines, including Biochemistry and Immunology. While working in this field, Jean-Claude Dujardin studies both Visceral leishmaniasis and Leishmania infantum.
A significant part of his Gene research incorporates Genotype and Genome studies. Leishmaniasis is frequently linked to Pathology in his study. His Leishmaniasis research extends to the thematically linked field of Pathology. Parasite hosting is closely attributed to Miltefosine in his study. His study deals with a combination of Miltefosine and Leishmania donovani. His Leishmania donovani study frequently draws connections between adjacent fields such as World Wide Web. His World Wide Web study frequently links to other fields, such as Leishmania. Jean-Claude Dujardin integrates Leishmania with Visceral leishmaniasis in his research. He integrates many fields in his works, including Visceral leishmaniasis and Amastigote.
Jean-Claude Dujardin works mostly in the field of Demography, limiting it down to concerns involving Population and, occasionally, Environmental health. His research on Environmental health often connects related topics like Population. In his research, he performs multidisciplinary study on Gene and Biochemistry. Jean-Claude Dujardin conducted interdisciplinary study in his works that combined Biochemistry and Gene. He combines Genetics and Molecular biology in his research. Jean-Claude Dujardin integrates Molecular biology with Genetics in his research. In his papers, he integrates diverse fields, such as Genome and Whole genome sequencing. By researching both Whole genome sequencing and DNA sequencing, he produces research that crosses academic boundaries. He integrates several fields in his works, including DNA sequencing and Copy-number variation.
Gene and Virology are two areas of study in which Jean-Claude Dujardin engages in interdisciplinary work. He brings together Virology and Gene to produce work in his papers. He merges Genetics with Microbiology in his research. He performs multidisciplinary study on Microbiology and Genetics in his works. He undertakes multidisciplinary investigations into Leishmaniasis and Leishmania donovani in his work. He incorporates Leishmania donovani and Leishmania infantum in his studies. Jean-Claude Dujardin combines Leishmania infantum and Visceral leishmaniasis in his studies. His work blends Visceral leishmaniasis and Leishmania studies together. With his scientific publications, his incorporates both Leishmania and Leishmaniasis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cutaneous leishmaniasis – Authors' reply
Richard Reithinger;Richard Reithinger;Jean-Claude Dujardin;Hechmi Louzir;Claude Pirmez.
Lancet Infectious Diseases (2008)
Molecular diagnosis of leishmaniasis: current status and future applications.
Richard Reithinger;Richard Reithinger;Richard Reithinger;Jean-Claude Dujardin.
Journal of Clinical Microbiology (2007)
Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy
Julius Lukeš;Isabel L. Mauricio;Gabriele Schönian;Jean Claude Dujardin.
Proceedings of the National Academy of Sciences of the United States of America (2007)
Drug resistance and treatment failure in leishmaniasis: A 21st century challenge
Alicia Ponte-Sucre;Francisco Gamarro;Jean-Claude Dujardin;Michael P. Barrett.
PLOS Neglected Tropical Diseases (2017)
Spread of Vector-borne Diseases and Neglect of Leishmaniasis, Europe
Jean-Claude Dujardin;Lenea Campino;Carmen Cañavate;Jean-Pierre Dedet.
Emerging Infectious Diseases (2008)
Chromosome and gene copy number variation allow major structural change between species and strains of Leishmania
Matthew B. Rogers;James D. Hilley;Nicholas J. Dickens;Jon Wilkes.
Genome Research (2011)
Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance
Tim Downing;Hideo Imamura;Saskia Decuypere;Taane G. Clark.
Genome Research (2011)
Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis.
Jorge Arevalo;Jorge Arevalo;Luis Ramirez;Vanessa Adaui;Mirko Zimic.
The Journal of Infectious Diseases (2007)
Increasing Failure of Miltefosine in the Treatment of Kala-azar in Nepal and the Potential Role of Parasite Drug Resistance, Reinfection, or Noncompliance
Suman Rijal;Bart Ostyn;Surendra Uranw;Surendra Uranw;Keshav Rai.
Clinical Infectious Diseases (2013)
Efficacy of Miltefosine in the Treatment of Visceral Leishmaniasis in India After a Decade of Use
Shyam Sundar;Anup Singh;Madhukar Rai;Vijay K Prajapati.
Clinical Infectious Diseases (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: